top of page
Recent Posts
See AllThe European Commission has granted approval for the use of Rybrevant ( amivantamab) in combination with Lazcluze ( lazertinib) as a...
0
The European Commission (EC) has approved Kisqali (ribociclib) in combination with aromatase inhibitors (AI) for the treatment of...
0
Alhemo recommended for European approval as first daily subcutaneous prophylactic treatment for haemophilia A or B patients with...
0
bottom of page
Comments